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Abstract.  The polyphosphoinositides, PIP and PIP2, 
have been proposed to regulate actin polymerization in 
vivo because they dissociate actin/gelsolin complexes 
in vitro. We tested this hypothesis by comparing the 
ability of EGF and bradykinin to affect PI metabolism 
and the actin cytoskeleton in A431  cells. EGF, but not 
bradykinin,  was found to induce ruffling and dissocia- 
tion of actin/gelsolin complexes in these cells.  How- 
ever, both EGF and bradykinin stimulated the accumu- 
lation of inositol phosphates in [3H]inositol-labeled 
cells indicating that stimulation of PI turnover is not 
sufficient for the induction of changes in actin/gelsolin 
complex levels. EGF stimulated a twofold increase in 
the level of PIP in A431 cells.  Other phosphoinositide 
levels were not markedly altered.  Treatment of the 
cells with cholera toxin abrogated the EGF-induced 
rise in PIP levels without altering  the dissociation of 
actin from gelsolin.  These data indicate that increases 
in PIP and/or PIP2 are not necessary for dissociation 
of actin/gelsolin complexes. Overall, these experiments 
suggest that in A431  cells, the effects of EGF on the 
actin cytoskeleton are unlikely to be mediated through 
changes in PIP or PIP2 levels. 
T 
HE stimulation  of phosphoinositide turnover has been 
shown to be a central event in the transduction  of sig- 
nals via receptors for a variety of agents.  Hormone- 
stimulated cleavage of the polyphosphoinositide,  PIP2, yields 
two intracellular  second messengers,  diacylglycerol and ino- 
sitol 1,4,5,-trisphosphate  (29).  Diacylglycerol  activates pro- 
tein kinase C (21) while inositol 1,4,5-triphosphate  induces 
the release of calcium from intracellular  stores (3). For many 
hormones, the production of these two second messengers is 
thought to be the principal mechanism used by the hormone 
to bring about changes in the functions of intracellular  pro- 
teins and enzymes. 
Recently,  several  reports have  appeared  that  have  con- 
tradicted the current dogma that the only metabolic effects 
of phosphoinositides are due to their  role as substrates  for 
breakdown by phospholipase C. For example, the activity of 
the  sarcoplasmic  reticulum  Ca2+-ATPase appears  to  be 
stimulated  directly by binding  of PIP  or  PIP2 (15). The 
function of two cytoskeletal proteins; profilin and gelsolin, 
also  appears to  be  regulated  by  polyphosphoinositides. 
Profilin forms a 1:1 complex with actin monomers inhibiting 
polymerization (32).  Polyphosphoinositides  dissociate the 
profilin/actin  complexes,  promoting  actin  polymerization 
(25, 27). Gelsolin is an 87-kD protein that severs, caps, and 
nucleates actin  filaments  in vitro in  a  calcium-dependent 
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fashion. Each of these processes results in gelsolin bound to 
the barbed end of an actin filament (32). This actin/gelsolin 
complex  is  stable  to  EGTA  but  is  dissociated  by poly- 
phosphoinositides  (6, 7, 20, 23). 
The effects of polyphosphoinositides on profilin and gelso- 
lin  in vitro may serve to regulate  actin  polymerization in 
vivo. Treatment ofplatelets with thrombin results in the stim- 
ulation of PI turnover (33, 44) and is associated with changes 
in  actin  filament  concentration  and  distribution  (16, 27). 
Lind et al.  (27) demonstrated that  in thrombin-stimulated 
platelets  gelsolin  and profilin are rapidly converted  from a 
free form to one in which they are bound to actin  in high 
affinity  1:1  complexes.  After several  minutes,  these com- 
plexes dissociate and the gelsolin and profilin are once again 
free in the cytosol. More recent work by Hartwig et al. (17) 
suggests that thrombin may induce the association of gelsolin 
with the cell membrane, positioning  it in proximity to the 
regulatory polyphosphoinositides. 
Based on these findings, a model has been proposed to ex- 
plain the thrombin-induced changes in the actin cytoskeleton 
of platelets  (27, 28, 38). In this model, gelsolin is first acti- 
vated via the rapid increase in intraceUular calcium resulting 
from the breakdown of PIP2 and the generation  of inositol 
1,4,5-trisphosphate.  Gelsolin then caps, nucleates,  or severs 
actin  filaments  resulting  in the formation  of actin/gelsolin 
complexes  in which gelsolin  is bound to the barbed end of 
actin  filaments.  A subsequent rise in polyphosphoinositide 
levels due to resynthesis  of metabolized lipids releases the 
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ization at the newly created free barbed ends. Consistent 
with this model is the observation that the membranes of 
neutrophils exhibit an increased ability to nucleate actin po- 
lymerization after treatment with a chemotactic peptide (8). 
EGF induces membrane ruffling (12) and a change in the 
distribution of the actin-based cytoskeleton in A431  cells 
(35),  a  human epidermoid carcinoma cell line.  EGF also 
stimulates turnover of phosphoinositides, activates a PI ki- 
nase, and induces a rise in the levels of PIP (31, 43). In light 
of these observations, we tested the hypothesis that EGF- 
induced changes in polyphosphoinositide levels affect the ac- 
tin cytoskeleton and cell motility by altering actin/gelsolin 
and actin/profilin interactions. We report here that although 
EGF induces an increase in PIP levels and a concomitant de- 
crease in actin/gelsolin complexes, the two effects of the 
growth  factor  can  be  completely  dissociated  in  cholera 
toxin-treated cells. In addition, bradykinin stimulates more 
extensive PI turnover than EGF but does not cause dissocia- 
tion of actin/gelsolin complexes indicating that breakdown of 
polyphosphoinositides is not always associated with changes 
in the actin cytoskeleton. 
Materials and Methods 
Materials 
EGF was purified according to the method of Savage and Cohen (34). Myo- 
[3H]inositol was from American Radiolabelled Chemicals, Inc., St. Louis, 
MO. Rhodamine-phalloidin was from Molecular Probes Inc., Eugene, OR. 
Anti-gelsolin monoclonal antibody 2C4  (9)  (Sigma Chemical  Co.,  St. 
Louis, MO) was purified and coupled to CNBr-Sepharose (5). Anti-actin 
mouse monoclonal antibody (C4), a gift of Dr. James Lessard (University 
of Cincinnati, OH), recognizes all actin isoforms by immunoblot (26). Rab- 
bit plasma gelsolin was a  generous gift of Dr. Carl Frieden (Washington 
University, St. Louis, MO). 
Cell Culture 
A431  cells were maintained in Dulbecco's modified Eagle's medium con- 
taming 3% fetal calf serum and 7% newborn calf serum. For all experi- 
ments, cells were cultured so as to be 60-90% confluent at the time of use. 
Fluorescence Microscopy ofA431 Cells Stained with 
Rhodamine-PhaUoidin 
A431 cells grown on glass coverslips were incubated with EGF or bradyki- 
nin at 370C for various times. Cells were fixed with 3.7% formaldehyde in 
PBS for 15 min, permeabilized with PBS containing 0.2 % Triton X-100 for 
5 rain, and blocked by a 30-min incubation in PBS containing 1% bovine 
serum albumin and 10 mM Tris, pH 7.2.  The ceils were incubated with 
0.165 #M rhodamine-phalloidin in PBS for 10 min, washed three times with 
PBS, and mounted in PBS. A Zeiss IM-35 microscope with a 40x Planapo 
phase-contrast  objective, NA 0.65, was used for both phase and fluorescence 
microscopy. 
Assay  for Cell Content of  FUamentous Actin 
This assay is modified from that of Howard and Oresajo (19).  A431  cells 
in 96-well micro-titer plates were incubated with EGF or bradykinin at 
37*C. The cells were fixed with 3.7% formaldehyde in PBS for 15 rain and 
permeabilized with 0.2% Triton X-100 in PBS for 5 rain. The fixed, per- 
meabilized cells were  incubated  with  100  t~l  of 1.65 /~M  rhodarnine- 
phalloidin in PBS for 15 rain which was sufficient to saturate the filamen- 
tous actin in these samples. The wells were washed three times with PBS 
and dissolved in 0.5 rnl 0.1 N NaOH and the fluorescence of each sample 
was determined using an SLM8000 fluorimeter (SLM Instruments, Inc., 
Urbana, IL). 
Immunoprecipitation of  EGTA-stable 
Actin/Gelsolin Complexes 
Actin/gelsolin  complexes were measured as described (9). A431 cells grown 
on 150-ram culture dishes were incubated with 30 nM EGF or  10 t~M 
bradykinin at 37"C and then extracted with Triton extraction buffer (9). Im- 
munoblots showed that all the gelsolin from both control and hormone- 
treated cells was in the soluble fraction. This supernatant was mixed with 
20/~1 of anti-gelsolin antibody-Sepharose beads and incubated for 1-2 h at 
4°C. The beads were washed once with Triton extraction buffer containing 
5 mM ATP, and then washed three times with 0.5 rnl of 50 mM Tris,  pH 
7.4,  0.5 M  NaCI,  1 mM EGTA, and 0.3  M  MgCI2.  Proteins associated 
with the beads were analyzed by SDS-PAGE (24) except that piperazine di- 
acrylamide  cross-linker  was  substituted  for  the  N,N'-methylene-bis- 
acrylamide cross-linking agent to reduce background upon silver staining. 
The positions of the actin and gelsolin bands were determined by comigra- 
tion with authentic samples of these proteins and by Western blotting with 
anti-actin and anti-gelsolin antibodies. Actin and gelsolin protein bands 
were quantitated by scanning laser densitometry. The molar ratio of actin 
to gelsolin was estimated by comparing the ratio of the ahsorhance of the 
actin band to that of the gelsolin band with the same ratio obtained under 
conditions which promoted the formation of a 1:1 complex of actin/gelsolin. 
1:1 complexes of actin/gelsolin were prepared by lysing cells and incubating 
the Triton-soluble fraction with anti-gelsolin antibody-Sepharose in the 
presence of 5 mM Ca  2+ followed by washing the beads with buffer contain- 
ing EGTA. 
Isolation and Quantitation of 
Profilin/Actin Complexes 
Profilin/actin  complexes were  isolated  and  analyzed using  polyproline 
Sepharose as described (27). The ratio of profilin to actin was calculated 
assuming that on a per microgram basis profilin Coomassie blue stains with 
90% the intensity of actin (37). 
Measurement of  lnositol Phosphates and 
Inositol Phospholipids 
A431 ceils were grown in 35-ram plates and labeled overnight in Dulbecco's 
modified Eagle's medium containing 2 t~Ci/ml myo-[3H]inositol, 25  mM 
Hepes, pH 7.4,  7% dialyzed newborn calf serum, and 3% dialyzed fetal 
calf serum. 30 rain before treatment with hormone, 10 mM LiC1 was added 
to the cultures. EGF (30 nM) or bradykinin (10/~M) were added to the cul- 
tures for the times indicated and the cells incubated at 37°C. For inositol 
phosphate analysis,  the  incubations  were  terminated by  aspirating  the 
medium from the cultures and precipitating the monomers with cold 5% 
trichloroacetic acid.  Samples were then analyzed by chromatography on 
Dowex columns as described previously (13). For analysis of inositol phos- 
pholipids, incubations were terminated by aspirating the medium and add- 
ing 2.25 ml methanol/cone. HC1 (10:1). Lipids were extracted with chloro- 
form and analyzed by thin layer chromatography as described (31). 
Results 
Morphological Changes in A431 Cells 
As shown in Fig.  1,  unstimulated A431  cells exhibited a 
spread morphology with a thin peripheral region of cyto- 
plasm that lacks vesicles. Occasional ruffles were observed 
at the periphery of cells. Within 30 s after the addition of 
EGE the size and number of ruffles increased. The response 
peaked between 2 and 5 rain. By 10 rain the ruffling had sub- 
sided and the cell margins had begun to retract. Fixation of 
the  cells  followed by  staining with  rhodamine-phalloidin 
confirmed the presence of filamentous actin in these ruffles 
(data not shown). By contrast, no change in the extent of cell 
ruffling was observed for up to 20 min after the addition of 
bradykinin. 
Changes in the Actin Cytoskeleton 
To determine whether EGF or bradykinin stimulated changes 
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in A431 cells.  A431 cells were treated  with 30 nM EGF for the 
times indicated and Triton X-100-soluble extracts prepared as de- 
scribed  in  Materials  and  Methods.  The  free  gelsolin  and  ac- 
tin/gelsolin complexes were isolated by adsorption to anti-gelsolin 
antibody-coupled  Sepharose.  The immunoprecipitates  were ana- 
lyzed  by SDS-PAGE and the protein  bands  visualized  by silver 
staining.  The antibody only  lane is a control  in which the anti- 
gelsolin antibody-coupled  Sepharose beads have not been exposed 
to cell extract before electrophoresis. The positions of  the actin and 
gelsolin bands are indicated by A and G. Numbers on the right refer 
to the positions of molecnlar mass markers in kilodaltons. 
in the association of actin with gelsolin, EGTA-stable actin/ 
gelsolin complexes from hormone-treated A431  cells were 
isolated as described in Materials and Methods. Fig. 2 shows 
a  silver-stained SDS-polyacrylamide gel of the complexes 
present in A431  cells treated with EGF. While the level of 
gelsolin was relatively constant throughout the time course, 
a decrease in the level of actin, which is proportional to the 
level of actin/gelsolin complexes, was apparent as early as 
15 s after the addition of EGF. The levels of actin remained 
low for the remainder of the time course. 
EGF,  but  not  bradykinin,  decreased  the  level  of  ac- 
tin/gelsolin complexes (Fig.  3).  In untreated control cells, 
the average molar ratio of actin/gelsolin was 0.5 but ranged 
from 0.3  to  0.9  in  different experiments.  EGF  induced  a 
rapid and sustained 40-50% decrease in the level of EGTA 
stable actin/gelsolin complexes. Paired t-test analysis of the 
five  experiments  with  EGF  indicated  that  the  observed 
changes  in  actin  were  significant  at  the  P  <0.05  level. 
Bradykinin stimulated no consistent change in the level of the 
actin/gelsolin complexes in A431  cells.  Additional experi- 
ments  demonstrated  that  treatment  of  A431  cells  with 
bradykinin for 10, 20, or 30 s did not result in a decrease in 
actin/gelsolin complexes (data not shown). Thus, bradykinin 
induced  neither  short-term  nor  long-term changes  in  ac- 
tin/gelsolin complex levels. 
Using  polyproline  agarose  to  isolate  profilin  and  as- 
Figure 1.  The effect of EGF (left) and bradykinin  (right) on A431 
cell morphology. A431 cells were grown on coverslips and main- 
tained at 37°C in Dulbecco's modified Eagle's medium during mi- 
croscopy. Numbers  in the upper left corner indicate the time in 
minutes after the addition of 30 nM EGF or 10/~M bradykinin. Bar, 
10 pm. 
Dadabay et al. Actin/Gelsolin Complexes in EGF-treated A431 Cells  1153 A 
o~oo 
~  6o 
z 
"° 
_z 
TIME  (Min) 
B 
"6~  140  I 
=  12oF 
°  .....  t  ........ 
z  s0 
g 
<  60I  t  I  i  I  ,j  i 
0  2  4  6  8  "  15 
TIME  (Min) 
Figure 3.  Time course of the effect  of EGF and bradykinin on 
EGTA-stable actin/gelsolin complexes. Triton-soluble extracts were 
prepared from A431 cells incubated with 30 nM EGF (A) or 10/~M 
bradykinin (B) for the times indicated. EGTA-stable actin/gelsolin 
complexes were immunoprecipitated  from the extracts and ana- 
lyzed by SDS polyacrylamide gel electrophoresis.  The data are 
presented as the percent change in the actin/gelsolin ratio and repre- 
sent the mean  +  standard error of five separate experiments for 
EGF and four separate experiments for bradykinin. 
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Figure 5. Time course of the effect of EGF and bradykinin on inosi- 
tol phosphate accumulation in A431 cells.  A431 cells were labeled 
for 16-20 h with myo-[3H]inositol. Cells were then incubated with 
30 nM EGF (left) or 10/~M bradykinin (right) for the times indi- 
cated. The soluble inositol phosphates were then isolated and ana- 
lyzed as described in Materials and Methods. Values represent the 
mean +  standard deviation of quintuplicate determinations from a 
representative experirnent. 
sociated actin from cell extracts, no change in the ratio of ac- 
tin to profilin  could  be documented  in  A431  cells  treated 
with EGF for periods of time ranging from 30 s to 20 min 
(data not shown). At 2 min after the addition of EGF, a point 
at which  maximal dissociation  of actin/gelsolin  complexes 
bad occurred, the actin/profilin ratio was 0.22 +  0.04 in con- 
trol cells and 0.20 +  0.03 in cells treated with EGF (n =  3). 
EGF rapidly stimulated an increase in the level of F-actin 
and this increase was maintained for at least 20 min (Fig. 4). 
Bradykinin transiently increased the F-actin content of A431 
ceils. 
Polyphosphoinositide Metabolism in,4431 Cells 
Both EGF and bradykinin  stimulated  PI turnover in A431 
cells (Fig.  5).  EGF stimulated a rapid increase to  140%  of 
control  in the  level of IP3.  Slower but  more sustained  in- 
creases in the levels of IP and IP~ were stimulated by EGF 
with  the  maximal  increase  being  two-  to  threefold.  The 
effects of bradykinin on PI turnover were more pronounced. 
Bradykinin stimulated a rapid but transient fourfold increase 
in  IP3 production.  In addition,  this  hormone  stimulated  a 
four- to fivefold increase in IP and IP2 production over the 
20-rain  time course. 
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Figure 4. Time course of the effect of EGF and bradykinin on F-actin 
content of A431 ceils.  A431 cells grown in 24-well dishes were in- 
cubated with 30 nM EGF or 10 ~M bradykinin for the times indi- 
cated. The cells were then fixed and permeabilized and the binding 
of rhodamine-phalloidin  assessed as described in Materials and 
Methods. Values represent the mean +  standard deviation of data 
from two separate experiments performed in quadruplicate. 
EGF and bradykinin elicited markedly different effects on 
the levels of phosphoinositides  in A431  cells.  As shown in 
Fig. 6, left EGF stimulated a significant increase in the level 
of PIP (31) that peaked at 2  min,  well after the changes in 
actin/gelsolin complexes or F-actin content. The levels of PI 
increased slightly over the time course but the levels of PIP2 
remained essentially constant.  Bradykinin  failed to signifi- 
cantly  alter  the  levels  of either  PI  or  PIP,  although  there 
was a small, transient decrease in the level of PIP2 (Fig.  6, 
right). 
Effect of Cholera Toxin on PIP and Actin/Gelsolin 
Complex Levels 
We have reported previously that cholera toxin ablates the 
ability of EGF to stimulate a rise in PIP levels in A431 cells 
but does not alter the ability of the hormone to stimulate PI 
turnover (31). Treatment of cells with cholera toxin blocked 
2~  EGF  •  Pl  Brodykimn 
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Figure 6. Time course of the effect of EGF and bradykinin on phos- 
phoinositide levels in A431 cells. A431 cells were labeled for 16- 
20 h with myo-[SH]inositol. Cells were then incubated with 30 nM 
EGF (left) or 10/~M bradykinin (right) for the times indicated. The 
inositol phospholipids were then isolated and analyzed as described 
in Materials and Methods. Values represent the mean +  standard 
deviation  of quintuplicate  determinations  from a  representative 
experiment. 
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Figure 7. Effect of cholera toxin treatment on the ability of EGF 
to stimulate changes in the levels of PIP (A) and actin/gelsolin com- 
plexes (B).  For determination of PIP levels, A431 cells were la- 
beled with [~H]inositol  for 16-20 h. Half the cultures were treated 
with 5 #g/ml cholera toxin for 3 h at 37°C. Half of the control and 
half of the cholera toxin-treated cultures were then incubated for 
4 min with 30 nM EGF. The inositol phospholipids were isolated 
and analyzed as described in Materials and Methods. Data shown 
represent the mean +  standard deviation from sextuplicate deter- 
minations from a representative experiment. For determination of 
actin/gelsolin complex levels, cultures of A431 cells were treated 
in the absence or presence of 5 #g/ml cholera toxin for 3 h at 37°C 
and then half of the cultures were treated with 30 nM EGF for 4 
min. Triton-soluble extracts were prepared from the cultures and 
actin/gelsolin complexes isolated  and  analyzed as described  in 
Materials and Methods. Data shown represent mean +  standard 
deviations from triplicate  determinations  from a  representative 
experiment. 
the ability of EGF to stimulate a rise in PIP levels (Fig. 7 
A) but did not affect the ability of EGF to induce dissociation 
of actin/gelsolin complexes (Fig. 7 B). Microscopic observa- 
tion of control and cholera toxin-treated cells demonstrated 
that  both  cultures  ruffled in  response  to  EGF  (data  not 
shown). 
Discussion 
Changes in polyphosphoinositide levels have been PrOpoSed 
to mediate hormone-induced alterations in the cytoskeleton 
of platelets (27), neutrophils (18), and macrophages (10, 17) 
through alterations in actin/gelsolin interactions.  In vitro, 
gelsolin can cap, nucleate, or sever actin and each process 
results in gelsolin bound to the barbed end of an actin fila- 
ment. Actin/gelsolin complexes, as detected in our assay, are 
most likely derived from gelsolin bound to the barbed end 
of actin  filaments  in  cells.  Release  of gelsolin  from the 
barbed ends is detected in our assay as a decrease in levels 
of actin/gelsolin complexes. This creates a free barbed end 
that can grow or shrink and a free gelsolin that may be reacti- 
vated by loss of bound phosphoinositide. 
We investigated the effects of EGF and bradykinin on both 
phosphoinositide  metabolism  and  changes  in  the  actin 
cytoskeleton in A431 cells, a cultured cell system. Our data 
on the actin cytoskeleton in A431 cells are in general agree- 
ment with the findings in other systems (10, 17, 18, 27). EGF 
altered the motility and shape of A431 cells, increased the 
F-actin content, and decreased the actin/gelsolin complex 
level. Our findings are consistent with the hypothesis that the 
dissociation of gelsolin from the barbed ends of actin ilia- 
ments  (manifested as  decreased actin/gelsolin complexes) 
facilitates  the  polymerization  of actin  and  suggest  that 
ruffling in A431 cells is associated with changes in the bio- 
chemistry of the actin cytoskeleton. Also consistent with this 
hypothesis  was  the  observation  that  bradykinin  did  not 
stimulate membrane ruffling and did not change the level of 
actin/gelsolin complexes. Bradykinin did stimulate a tran- 
sient rise in the level of F-actin in the cells. The molecular 
basis for this effect is unknown. 
Despite the fact that only EGF stimulated a change in the 
level of actin/gelsolin complexes, both EGF and bradykinin 
stimulated PI turnover in A431 cells. Thus, there appears to 
be no direct correlation between the ability of a hormone to 
stimulate  the  production  of  diacylglycerol  and  inositol 
trisphosphate and its ability to induce dissociation of gelsolin 
from actin. The fact that EGF, but not bradykinin, induced 
changes in actin/gelsolin complexes argues against the hy- 
pothesis that flux through the PI pathway is sufficient to in- 
duce  changes  in  these  complexes.  If this  were the  case, 
bradykinin would be expected to be more effective  than EGF 
in inducing complex dissociation since the former stimulates 
a more rapid and robust turnover of PI. 
Examination of the inositol phospholipid levels in cells 
stimulated with EGF demonstrated that the levels of PIP in- 
creased during the time that actin-gelsolin complexes were 
becoming dissociated. However, the effect of EGF on poly- 
phosphoinositide levels was somewhat slow compared to its 
effect on actin/gelsolin complexes. In addition,  the effects 
of EGF on PIP levels could be dissociated from the effects 
of this hormone on actin/gelsolin complexes by treatment of 
cells with cholera toxin. This toxin blocked the ability of 
EGF to induce the rise in PIP levels without altering the 
effects of the growth factor on actin/gelsolin complexes. Al- 
though effects mediated through changes in lipid aggregation 
and/or localization cannot be ruled out, the most straightfor- 
ward interpretation of these data is that the ability of EGF 
to  induce  dissociation  of actin/gelsolin  complexes is  not 
related  to  the  ability  of this  growth  factor  to  stimulate 
changes in PIP or PIP: levels. 
Several alternative hypotheses can be considered. It is pos- 
sible that the effect of EGF may be mediated by another form 
of polyphosphoinositide such  as  the  recently discovered 
phosphatidylinositol  3,4,5-trisphosphate.  This  compound 
has been identified in activated neutrophils (39), thrombin- 
stimulated platelets (22), CSF-l-stimulated macrophage cell 
lines (42), and PDGF-stimulated smooth muscle cells (2). 
Consistent with this possibility is the recent report of a corre- 
lation between increases  in phosphatidylinositol trisphos- 
phate levels and actin polymerization in chemoattractant- 
stimulated neutrophils (14). Alternatively, the EGF receptor 
is known to possess intrinsic tyrosine protein kinase activity 
(40,  41)  that is  required  for signal  transduction  (11, 28). 
Bradykinin is not known to stimulate the phosphorylation of 
proteins on tyrosine residues. Given the differences between 
the response of A431 cells to EGF and bradykinin, it is pos- 
sible that the EGF-induced changes in the actin cytoskeleton 
involve the phosphorylation on a tyrosine of a cytoskeletal 
protein. Several cytoskeletal proteins including vinculin (36), 
spectrin (1, 4), talin (30), and ezrin (4) are known to be sub- 
strates for tyrosine kinases. Further experiments will be re- 
quired to distinguish between these two hypotheses. 
Dadabay et al. Actin/Gelsolin Complexes in EGF-treated A431 Cells  1155 We are grateful to Dr. David Silbert and John Monsey for assistance with and 
the use of their fluorimeter. 
This work was supported by a grant from the Lucille P. Markey Charitable 
Trust. J. A. Cooper is a Lucille P. Markey Biomedical Scholar. 
Received for publication 10 August 1990 and in revised form 3 December 1990. 
References 
1. Akiyama, T.,  T. Kadowaki, E.  Nishida, T. Kadooka, H. Ogawara, Y. 
Fukami, H. Sakai, F. Takaku, and M. Kasuga. 1986. Substrate specifici- 
ties of tyrosine-specific protein kinases toward cytoskeletal proteins in 
vitro. J. Biol.  Chem. 261:14797-14803. 
2. Auger, K. R., L. A. Serunian, S. P. Soltoff,  P. Libby, and L. C. Cantley. 
1989.  PDGF-dependent tyrosine phosphorylation stimulates production 
of novel polyphosphoinositides in intact cells. Cell. 57:167-175. 
3. Bcrridge, M. J.  1984.  Inositoi trisphosphate and diacylglycerol as second 
messengers. Biochem. J.  220:345-360. 
4. Bretscber, A. 1989. Rapid phosphorylation and reorganization of ezrin and 
spectrin accompany morphological changes induced in A431--cells by 
epidermal growth factor. J.  Cell Biol.  108:921-930. 
5. Bruck,  C.,  D.  Porteteile,  C. Glineur,  and A.  Bollen.  1982.  One-step 
purification of mouse monoclonal antibodies from ascitic fluid by DEAE 
Affi-gel blue chromatography. J.  lmmunol.  Methods.  53:313-319. 
6. Bryan, J., and L. M. Coinccio.  1985. Kinetic analysis of F-actin depoly- 
merization in the presence of platelet gelsolin and gelsolin-actin com- 
plexes. J.  Cell Biol. 101:1236-1244. 
7. Bryan, J., and M. C. Kurth. 1984. Actin-gelsolin interactions: evidence for 
two actin-binding sites. J.  Biol.  Chem. 259:7480-7487. 
8. Carson, M., A. Weber, and S. H. Zigmond. 1986. An actin-nucleating ac- 
tivity in polymorphonuclear leukocytes is modulated by chemotactic pep- 
tides. J.  Cell Biol. 103:2707-2714. 
9. Chaponnier, C.,  P.  A.  Ianmey, and H.  L.  Yin.  1986.  The actin fila- 
ment-severing domain of plasma gelsolin. J.  Cell Biol.  103:1473-1481. 
10. Chaponnier, C., H. L. Yin, and T. P. Stossel. 1987. Reversibility ofgelso- 
lin/actin interaction in macrophages. Evidence of CaZ+-dependent and 
Ca2+-independent  pathways. J.  E~. Med.  165:97-106. 
11. Chen, W.  B.,  C.  S.  Lazar,  M.  Poenie,  R.  Y.  Tsien, G.  N.  Gill,  and 
M. G. Rosenfeld.  1987.  Requirement for intrinsic protein tyrosine ki- 
nase in the immediate and late actions of the EGF  receptor.  Nature 
(Lond.).  328:  820-823. 
12. Chinkers, M., J. A. McKanna, and S. Cohen. 1979.  Rapid induction of 
morphological changes in human carcinoma ceils A-431 by epidermal 
growth factor. J.  Cell Biol. 83:260-265. 
13. Dowries,  C. P., and R. H. Michell. 1981. The polyphosphoinositide phos- 
phodiesterase of erythrocyte membranes. Biochem. J.  198:133-140. 
14. Eberle, M., A. E. Traynor-Kaplan, L. A. Sldar, and J. Norgauer. 1990. 
Is there a  relationship between phosphatidylinositol trisphosphate and 
F-actin polymerization in human neutrophils? J. Biol. Chem. 265:16725- 
16728. 
15. Enyedi, A., M. Flura, B. Sarkadi, G. Gardos, and E. Carafoli. 1987. The 
maximal velocity and the calcium affinity of the red cell calcium pump 
may be regulated independently. J.  Biol. Chem. 262:6425-6430. 
16. Fox, J. E. B., J. K. Boyles, C. C. Reynolds, and D. R. Phillips. 1984. Actin 
filament content and organization in unstimulated platelets. J.  Cell Biol. 
98:1985-1991. 
17. Hartwig, J. H., K. R. Chambers, and T. P. Stossel. 1989. Association of 
gelsolin with actin filaments and cell membranes of macrophages and 
platelets. J.  Cell Biol.  108:467-479. 
18. Howard, T.,  C.  Chaponnier, H.  Yin, and T.  P.  Stossel.  1990.  Gelso- 
lin-actin interaction and actin polymerization in human neutrophils. J. 
Cell Biol. 110:1983-1991. 
19. Howard, T. H., and C. O.  Oresajo.  1985.  The kinetics of chemotactic 
peptide-induead change in F-actin content, F-actin distribution, and the 
shape of neutrophils. J.  Cell Biol. 101:1078-1085. 
20. Janmey, P. A., and T. P. Stossel.  1987.  Modulation of gelsolin function 
by phosphatidylinositol  4,5-bisphosphate. Nature (Lond.). 325:362-364. 
21. Kishimoto, A., Y. Takai, T. Mori, U. Kikkawa, and Y. Nishizuka. 1980. 
Activation of calcium and phospholipid-dependent protein kinase by di- 
acylglycerol, its possible relation to phosphatidylinositol turnover. J. 
Biol.  Chem. 255:2273-2276. 
22. Kucera, G. L., and S. E. Rittenhouse. 1990. Human platelets form 3-phos- 
phorylated phosphoinositides in response to cc-thrombin,  U46619, or 
GTP3,S. J.  Biol. Chem. 265:5345-5348. 
23. Kurth, M. C., and J. Bryan. 1984. Platelet activation induces the formation 
of a  stable gelsolin-actin complex from monomeric gelsolin. J.  Biol. 
Chem. 259:7473-7479. 
24. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly 
of the head of bacteriophage T4. Nature  (Lond.). 227:680-685. 
25. Lassing, L, and U. Lindberg. 1985. Specific interaction between phosphati- 
dylinositol 4,5-bisphosphate and profilactin.  Nature  (Lond.).  314:472- 
474. 
26. Lessard, J. L. 1988. Two monoclonal antibodies to actin: one muscle selec- 
tive and one generally reactive.  Cell Motil.  Cytoskel.  10:349-362. 
27. Lind, S. E., P. A. Janmey, C. Chaponnier, T.-J. Herbert, and T. P. Stossel. 
1987. Reversible binding of actin to gelsolin and profilin in human plate- 
let extracts. J.  Cell Biol. 105:833-842. 
28. Moolenaar, W. H., A. J. Bierman, B. C. Tilly, I. Verlaan, L. H. K. Defize, 
A. M. Honegger, A. Ulrich, and J. SchIessinger. 1988. A point mutation 
at the ATP-binding site of the EGF-receptor abolishes signal transduc- 
tion. EMBO  (Fur. Mol. Biol. Organ.) J.  7:707-710. 
29. Nishizuka, Y.  1984. Turnover of inositol phospholipids and signal trans- 
duction. Science  (Wash. DC).  225:1365-1370. 
30. Pasquale, E.  B.,  P.  A.  Maher, and S. J.  Singer.  1986.  Talin is phos- 
phorylated on tyrosine in chicken embryo fibroblasts  transformed by 
Rous sarcoma virus. Proc. Natl. Acad.  Sci. USA. 83:5507-5511. 
31. Pike, L. J., and A. T. Eakes. 1987. Epidermal growth factor stimulates the 
production of phosphatidylinositol monophosphate  and the breakdown of 
polyphosphoinositides in A431 cells. J. Biol. Chem. 262:1644-1651. 
32. Pollard, T. D., and J. A. Cooper. 1986. Actin and actin-binding proteins. 
A critical evaluation of mechanisms  and functions. Annu. Rev. Biochem. 
55:987-1035. 
33. Rittenhouse, S.  E.  1983.  Human platelets contain phospholipase C  that 
hydrolyzes  polypbosphoinositides.  Proc.  Natl.  Acad.  Sci.  USA. 
80:5417-5420. 
34. Savage, C. R., and S. Cohen. 1972.  Epidermal growth factor and a new 
derivative. J.  Biol. Chem. 247:7609-7611. 
35. Schiessinger, J., and B. Geiger.  1981.  Epidermal growth factor induces 
redistribution of actin and a-actinin in human epidermal carcinoma cells. 
Exp.  Cell Res.  134:273-279. 
36. Sefton, M. B., T. Hunter, E. H. Ball,  and S. J. Singer. 1981.  Vinculin: 
a cytoskeletal target of the transforming protein of Rous sarcoma virus. 
Cell. 24:165-174. 
37. Southwick, F. S., and C. L. Young. 1990. The actin released from profilin- 
actin complexes is insufficient to account for the increase in F-actin in 
chemoattractant-stimulated  polymorphonuclear leukocytes. J.  Cell  Biol. 
110:1965-1973. 
38. Stossel, T. P. 1989. From signal and pseudopod. How cells control cyto- 
plasmic actin assembly. J.  Biol. Chem. 264:18261-18264. 
39. Traynor-Kaplan, A. E., A. L. Harris, B. L. Thompson, P. Taylor, and 
L. A. Sldar.  1988.  An inositol tetrakisphosphate-containing phospho- 
lipid in activated neutrophils. Nature  (Lond.).  334:353-356. 
40. Ullrich, A., L. Coussens, J. S. Hayflick, T. J. Dull, A. Gray, A. W. Tam, 
J. Lee, Y. Yarden, T. A. Libermann, J.  Schlessinger, J. Downward, 
E. L. V. Mayes, N.  Whittle, M.  D.  Waterfield, and P.  H.  Seeburg. 
1984.  Human epidermal growth factor receptor cDNA sequence and 
aberrant expression of the amplified gene in A431 epidermoid carcinoma 
cells. Nature  (Lond.). 309:418--425. 
41. Ushiro, H., and S. Cohen.  1980.  Identification  of phosphotyrosine as a 
product of epidermal growth factor-activated  protein kinase in A-43  l cell 
membranes. J.  Biol. Chem. 255:8363-8365. 
42. Varticovski, L., B. Druker,  D.  Morrison, L.  Cantley, and T.  Roberts. 
1989. The colony stimulating factor-1  receptor associates with and acti- 
vates phosphatidylinositol-3 kinase. Nature  (Lond.).  342:699-702. 
43. Walker, D. H., and L. J. Pike.  1987. Phosphatidylinositol kinase is acti- 
vated in membranes  derived from cells treated with epidermal growth fac- 
tor. Proc. Natl. Acad.  Sci. USA. 84:7513-7517. 
44. Wilson, D. B., E. J. Neufeld, and P. W. Majerus. 1985. Phosphoinositide 
interconversion in thrombin-stimulated human platelets. J. Biol. Chem. 
260:1045-1051. 
The Journal of Cell Biology, Volume 112,  1991  1156 